| Author | Ray, Gaurav |
| Call Number | AIT RSPR no. SM-99-29 |
| Subject(s) | Vaccines--Marketing
|
| Note | A research study submitted in partial fulfillment of the requirements for the degree of
Master of Business Administration, School of Management |
| Publisher | Asian Institute of Technology |
| Abstract | At the very outset the reader is informed that all the names of products and
companies have been changed to maintain confidentiality. There are no vaccines for
malaria as of now and all the treatment recommended in this report do not confirm to
any known disease. The purpose of this report is to understand and develop
marketing case studies relating to the pharmaceutical industry.
The objective of this report is to put forward in a simple way the strategies that are to
be taken into account while launching a vaccine. Malaria has often caused havoc to
large populations, specially in the developing countries. A company called Supreme
Vaccine Company (SVC) is a key player in the vaccine market. SVC already has two
well developed vaccines for treating malaria. It is planning to launch an improved
version of the existing malaria vaccine which is expected to replace the older
versions. Competition, product life-cycles and the recent merger of SVC's parent
company with another life sciences business group has been taken into account while
studying the launch dynamics for the new malaria vaccine. |
| Year | 1999 |
| Type | Research Study Project Report (RSPR) |
| School | School of Management |
| Department | Other Field of Studies (No Department) |
| Academic Program/FoS | Master of Business Administration (MBA) (Publication code=SM) |
| Chairperson(s) | Bechter, Clemens; |
| Examination Committee(s) | Johri, Lalit M.;Speece, Mark; |
| Scholarship Donor(s) | Asian Institute of Technology Partial Scholarship; |
| Degree | Research Studies Project Report (M.B.A.) - Asian Institute of Technology, 1999 |